Pets & Psychedelics | A Call for Harm Reduction
A Veterinarian’s Call for Harm Reduction in Psychedelic Medicine
IMPORTANT: Disclaimer - this essay does not provide endorsement or instructions for providing psychedelic medicines to animals. Keep these risk reduction actions in mind at all times when working with a psychedelic substance in close proximity to an animal.
Psychedelic exposure in pets could be a medical emergency. If your animal is exposed, please contact your veterinarian or a poison-control hotline.
Between Hope and Fear
As a veterinarian who has spent the past years exploring the intersection of animal health and the growing world of psychedelic medicine, today, I find myself both hopeful and uneasy.
On the one hand, the possibility that psychedelic could offer new ways to ease suffering in animals is deeply compelling—especially when we think of patients whose behavioral disease or trauma lead to relinquishment or euthanasia.
On the other hand, I am increasingly alarmed by the speed and certainty with which new studies are translated into bold claims, amplified by flashy headlines, and absorbed by the public as fact.
When news circulates about “miracle psychedelic fixes for pets,” what happens in reality? Pet guardians, already flooded by online advice and anecdotal reports, may begin to experiment at home—often without veterinary guidance, without harm-reduction strategies, and without awareness of the risks.
The line between scientific exploration and cultural amplification is dangerously thin, and animals — who cannot consent — bear the consequences.
This is why I write today.
Not to condemn research, nor to discourage curiosity, but to advocate for something urgently needed in this emerging psychedelic landscape: harm reduction for all beings.
Clickbait, Culture, and the Ripple Effects of Research
We live in an ecosystem of information where attention is currency.
Scientific nuance rarely makes it into headlines; what does, are sweeping statements stripped of context. In human psychedelic research, we have seen it before: “cure-alls for depression” or, “healing trauma in a single session”. These are not outright fabrications, but they are distortions—fragments of complex studies & traditions reframed to feed an eager public narrative of miracle cures.
Now, veterinary psychedelics are entering this same cultural current.
Early pilot studies are quickly reframed into popular articles that overstate results and ignore caveats. A non-controlled, time-limited, single patient trial becomes an internet claim that “LSD is safe for dogs.”
A laboratory observation of ayahuasca in monkeys is retold as a cultural endorsement of psychedelics for animals. Online forums and social media then amplify these messages further, often with humor or casualness—homemade psilocybin treats for cats, or tales of “tripping dogs” are shared as amusing anecdotes.
This is more than miscommunication; it is harm in the making.
Just as sensational headlines in human psychedelics have fueled both unrealistic expectations and unsafe underground use, so too will they shape what pet guardians believe is safe, possible, or even compassionate for their animals.
One Health Mirror: Cannabis, Psychedelics, and Cultural Context
To understand where we are, it helps to look at a parallel: cannabis.
In both human and veterinary medicine, cannabis has followed a tumultuous arc —from illegality and stigma, to appropriation and commercialization, to the emergence of pharmaceutical derivatives. Along the way, cultural practices and sacred traditions have often been erased or commodified, while misinformation and exaggerated claims about safety and efficacy have spread widely.
We are now watching psychedelics follow a concerningly similar trajectory.
In human health, psychedelics are moving rapidly from Indigenous roots and underground use into pharmaceutical pipelines and wellness markets. In veterinary medicine, we see the beginnings of that same shift—early para-scientific studies, enthusiastic headlines, curious guardians, and an emerging underground.
The OneHealth framework reminds us that human, animal, and environmental health are inseparable.
The ways we treat animals often mirror the ways we treat ourselves. If we are prone to bypassing complexity, romanticizing healing, or chasing miracle cures in our own use of psychedelics, it is likely we will project these same tendencies onto the animals in our care.
The risk is compounded by the fact that animals cannot speak for themselves, and veterinary oversight is often absent.
Toward a Harm Reduction Framework in Veterinary Psychedelic Medicine
If prohibition is not the answer, then what is?
I believe the answer lies in harm reduction—an approach grounded in compassion, pragmatism, and responsibility.
For veterinary and animal care professionals, this means:
Education & Preparation: Practitioners must be prepared for conversations about psychedelics, even if they do not endorse their use.
Just as with cannabis, clients will ask questions, and some will experiment regardless of professional advice. Silence or stigma will only push these conversations further underground.
Responding to Exposures: Veterinary teams are in immediate need of clear, evidence-based protocols for managing psychedelic exposures in animals.
The effects of psychedelic substances last long after the period of direct exposure, clinic management plans should include long term care protocols and progressive medical monitoring.
Community Dialogue: Veterinary professionals can help guide the public away from extremes—neither dismissing psychedelics as unworthy of study, nor glorifying them as risk-free solutions.
For researchers, this means:
Scientific Humility: Resist overstating findings. Early studies are stepping stones, not final verdicts.
Ethical Oversight: Ensure that animal welfare is not secondary to scientific or career ambitions.
Collaboration: Engage Indigenous communities and cultural practitioners not as sources to be mined, but as partners with wisdom and authority.
And for animal guardians, this means:
Slowing Down: Before acting on a headline, consider the gaps in knowledge, the risks to your pet, and the absence of veterinary consensus.
Seeking Guidance: Even if the conversation feels uncomfortable, your veterinarian is best positioned to help keep your animal safe.
Compassion, Not Experimentation: True compassion for animals means respecting their wellbeing, not projecting our healing journeys onto them.
The Human–Animal Bond and Ethical Responsibility
My motivation for entering this conversation is not to attack, but to encourage caution.
I know firsthand how deep and powerful the human–animal bond is. I have felt it with my own companions and witnessed it daily in practice. I have also seen the shadow side—when love blurs into desperation, when hope for a cure overrides caution, when projection replaces presence.
Psychedelics amplify. They can amplify healing, yes—but also ego, urgency, and illusion. In humans, this can lead to grandiose self-conceptions, spiritual bypassing, or unsafe behaviors. When extended to animals, the consequences can be even more troubling.
This is why harm reduction is so essential.
We do not build harm reduction frameworks because people are “bad” or “reckless.” We build them because people are human—imperfect, emotional, and sometimes desperate. And animals, entirely dependent on us, deserve that we act with the highest level of care.
A Call for Care, Not Prohibition
We are standing at the threshold of a new frontier in veterinary medicine. Early research suggests psychedelics are worth exploring. Popular culture is already running far ahead, with narratives of psychedelic miracle cures for pets circulating freely.
Somewhere in between lies the responsibility of our profession: to pause, to reflect, and to act with humility.
This is not about shutting the door on inquiry. It is about opening it carefully, with respect for the unknown, awareness of history, and a commitment to minimizing harm. It is about listening to science, to culture, and to the animals themselves, who rely on us for safety.
The Wild West of psychedelics has already arrived. We cannot deny it, but we can shape how we respond.
Let us choose compassion over sensationalism, harm reduction over urgency, humility over hubris. For the animals. For their guardians. And for the integrity of veterinary medicine.
Resources to Explore
Single-dose 1cp-LSD administration for canine anxiety: a pilot study
Acute effects of ayahuasca in a juvenile non-human primate model of depression
Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior
About the Author:
Steve Kruzeniski BSc DVM
Dr. Steven Kruzeniski is a companion animal veterinarian with further education and passion for One Health, Peer Support, Indigenous Wisdom, and Psychedelic Assisted Therapies.
For over a decade he has been living and working across The Americas, Africa & Asia. He currently resides in the Sacred Valley of Peru.
His work combines social veterinary service & educational advocacy for animal welfare; support of veterinary professional wellbeing; and Psychedelic Harm Reduction across species.